1



    AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 22, 1996
                                                   REGISTRATION NO. 333-________
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                         POST EFFECTIVE AMENDMENT NO. 1
                                  ON FORM S-8
                                       TO
                                    FORM S-4
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933


                             MATRIA HEALTHCARE, INC.              
             -----------------------------------------------------
             (Exact name of registrant as specified in its charter)


            Delaware                                     58-2205984        
 ----------------------------------        ------------------------------------
  (State or other jurisdiction of          (I.R.S. Employer Identification No.)
   incorporation or organization)          
                                           
                                           
   1850 Parkway Place, 12th Floor          
            Marietta, Georgia                              30067   
- - ---------------------------------------                 -----------
(Address of principal executive offices)                 (Zip Code)



               1983 HEALTHDYNE, INC. INCENTIVE STOCK OPTION PLAN;
                    HEALTHDYNE, INC. 1991 STOCK OPTION PLAN;
                    HEALTHDYNE, INC. 1993 STOCK OPTION PLAN;
             HEALTHDYNE, INC. 1985 NON-QUALIFIED STOCK OPTION PLAN;
           HEALTHDYNE, INC. NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN;
               TOKOS MEDICAL CORPORATION 1985 STOCK OPTION PLAN;
                                      AND
        TOKOS MEDICAL CORPORATION 1995 STOCK OPTION/STOCK ISSUANCE PLAN
                           (Full title of the plans)

                       --------------------------------

                             J. Brent Burkey, Esq.
                                General Counsel
                            MATRIA HEALTHCARE, INC.
                         1850 Parkway Place, 12th Floor
                             Marietta, Georgia 30067                      
                    ---------------------------------------
                    (Name and address of agent for service)



                                   770-423-4500                          
         ------------------------------------------------------------
         (Telephone number, including area code, of agent for service)


- - ------------------------------------------------------------------------------

                        CALCULATION OF REGISTRATION FEE


                                                                                                                         
- - ------------------------------------------------------------------------------------------------------------------------------
 Title of securities to be       Amount to be        Proposed maximum         Proposed maximum          Amount of registration
 registered                      registered (1)      offering price per       aggregate offering        fee (3)
                                                     share                    price
- - ------------------------------------------------------------------------------------------------------------------------------
                                                                                            
 Common Stock, par value $.01
 per share (together with
 associated common stock
 purchase rights)                2,860,895 shares             (2)                       (2)             $8,746
                                                                                                                         
- - ------------------------------------------------------------------------------------------------------------------------------


         (1)  In addition, pursuant to Rule 416(a) under the Securities Act of
1933, this registration statement also covers an indeterminate number of
additional shares which may be offered and issued to prevent dilution resulting
from stock splits, stock dividends or similar transactions as provided in the
plans described herein.

         (2)  All of the shares of Common Stock included in this post-effective
Amendment No. 1 have previously been registered and the applicable registration
fee paid.  Such shares consist of 2,860,895 shares of Common Stock which were
previously registered and included in the Registration Statement on Form S-4
(No. 333-00781) as originally filed with respect to shares issuable upon
exercise of options granted under the above-referenced plans and a registration
fee of $8,746 was paid in connection therewith.

         (3)  The required registration fees for all shares of Registrant's
Common Stock to be registered pursuant to this Registration Statement on Form
S-8 have been previously paid in connection with the prior registration of such
shares as described in Footnote 2 above.
   2

                                    PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.

         Matria Healthcare, Inc. ("Registrant") hereby incorporates by
reference into this registration statement a copy of the following:

                 (a)      Joint Proxy Statement/Prospectus of Healthdyne, Inc.
                 ("Healthdyne") and Tokos Medical Corporation (Delaware)
                 ("Tokos"), predecessors of the Registrant, filed as part of
                 Registrant's Registration Statement on Form S-4 (No.
                 333-00781) dated February 8, 1996 (the "Joint Proxy
                 Statement"); and

                 (b)      the description of the Registrant's capital stock
                 contained in the Joint Proxy Statement as it may be amended by
                 any amendment or report filed subsequent to the date of this
                 registration statement for the purpose of updating such
                 description.

         In addition, all documents filed subsequent to the date of this
registration statement by the undersigned Registrant pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended,
and prior to the filing of a post-effective amendment hereto, which either
indicates that all shares of common stock offered hereby have been sold or
deregisters any shares of such common stock then remaining, shall also be
deemed to have been incorporated by reference into this registration statement.
Any statement in a document incorporated or deemed to be incorporated by
reference herein shall be deemed to be modified or superseded for purposes of
this Registration Statement to the extent that a statement contained herein, or
in any other subsequently filed document that also is deemed to be incorporated
by reference herein, modifies or supersedes such statement.  Any statement so
modified or superseded shall not be deemed, except as so modified or
superseded, to constitute a part of this Registration Statement.

ITEM 4.  DESCRIPTION OF SECURITIES.

         Not applicable.


ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.

         The legality of the shares offered hereby is being passed upon for the
Registrant by Troutman Sanders LLP, Atlanta, Georgia.  Carl E. Sanders, a
director of the Registrant and the





                                      II-2
   3

Chairman of Troutman Sanders LLP, is the beneficial owner of 74,500 shares of
the Common Stock of the Registrant.


ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

                 The General Corporation Law of the State of Delaware ("DGCL")
permits a corporation to indemnify officers, directors, employees and agents
for actions taken in good faith and in a manner they reasonably believed to be
in, or not opposed to, the best interests of the corporation, and with respect
to any criminal actions, which they had no reasonable cause to believe was
unlawful.  The DGCL provides that a corporation may advance expenses of defense
(upon receipt of a written undertaking to reimburse the corporation if
indemnification is not appropriate) and must reimburse a successful defendant
for expenses, including attorney's fees, actually and reasonably incurred, and
permits a corporation to purchase and maintain liability insurance for its
directors and officers.  The DGCL provides that indemnification may not be made
for any claim, issue or matter as to which a person has been adjudged by a
court of competent jurisdiction, after exhaustion of all appeals therefrom, to
be liable to the corporation, unless and only to the extent a court determines
that the person is entitled to indemnity for such expenses as the court deems
proper.

                 The Registrant's Certificate of Incorporation limits
Registrant's directors' liability for monetary damages to Registrant and its
stockholders for breaches of fiduciary duty to the fullest extent permitted
under the DGCL.  In addition, the Registrant's Certificate of Incorporation
provides that Registrant shall, to the fullest extent permitted by law,
indemnify its directors and officers against any liability, losses or related
expenses which they may incur by reason of serving or having served as
directors and officers of Registrant.

                 The Registrant's Bylaws provide that each person who is
involved in any actual or threatened action, suit or proceeding, whether civil,
criminal, administrative or investigative, by reason of the fact that he or she
is or was a director, officer, employee or agent of Registrant, or is or was
serving at the request of the corporation as a director, officer, employee or
agent of another corporation or of a partnership, joint venture, trust or other
enterprise, including service with respect to an employee benefit plan, will be
indemnified by the corporation to the fullest extent permitted by the DGCL, as
the same exists or may hereafter be amended, against all costs, charges,
expenses, liabilities and losses reasonably incurred or suffered by such person
in connection therewith, and such indemnification will continue as to a person
who has ceased to be a director, officer, employee or agent and will inure to
the benefit or his or her heirs, executors and administrators; provided,
however, that Registrant will indemnify any such person seeking indemnification
in connection with a proceeding initiated by such person only if such
proceeding was authorized by Registrant's Board of Directors.  The right to
indemnification will be a contract right and will include the right to be paid
by Registrant the expenses incurred in defending any such proceeding in advance
of its final disposition; provided, however, that if the DGCL so requires, the
payment of such expenses incurred by a director or officer in advance of the
final disposition of a proceeding will be made





                                      II-3
   4

only upon delivery to Registrant of an undertaking, by or on behalf of such
director or officer, to repay all amounts so advanced if it will ultimately be
determined that such director or officer is not entitled to be indemnified.
Registrant may provide indemnification to employees and agents of Registrant
with the same scope and effect as the foregoing indemnification of directors
and officers.

                 The indemnification rights conferred by the Registrant's
Certificate of Incorporation are not exclusive of any other right to which a
person seeking indemnification may be entitled under any law, bylaw, agreement,
vote of stockholders or disinterested directors or otherwise.  Registrant may
maintain insurance on behalf of its directors, officers, employees and agents.
Additionally, the Agreement and Plan of Merger dated as of October 2, 1995, as
amended, by and among Tokos, Healthdyne and the Registrant requires such
insurance to be maintained by Registrant covering present and former officers,
directors, employees, trustees and agents of Tokos for a period of at least six
years from the Closing Date thereunder, subject to certain limitations.


ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED.

                 Not applicable.


ITEM 8.  EXHIBITS.



                 Exhibit
                 Number
                 ------
                               
                 4(a)             Shareholder Rights Agreement dated as of January 30, 1996 between the Registrant and
                                  SunTrust Bank

                 5                Opinion of Troutman Sanders LLP

                 23(a)            Consent of Ernst & Young LLP

                 23(b)            Consent of KPMG Peat Marwick LLP

                 23(c)            Consent of Troutman Sanders LLP (contained in opinion filed in Exhibit 5).






                                      II-4
   5


                 Exhibits listed above which have heretofore been filed with
the Securities and Exchange Commission and which were incorporated as noted
above are hereby incorporated herein by reference and made a part hereof with
the same effect as if filed herewith.


ITEM 9.  UNDERTAKINGS.

                 (a)      Rule 415 offerings.  The undersigned Registrant
                 hereby undertakes:

                          (1)     To file, during any period in which offers or
                          sales are being made, a post-effective amendment to
                          this registration statement:

                                  (i)      To include any prospectus required
                                  by Section 10(a)(3) of the Securities Act of
                                  1933;

                                  (ii)     To reflect in the prospectus any
                                  facts or events arising after the effective
                                  date of the registration statement (or the
                                  most recent post-effective amendment thereof)
                                  which, individually or in the aggregate,
                                  represent a fundamental change in the
                                  information set forth in the registration
                                  statement.  Notwithstanding the foregoing,
                                  any increase or decrease in volume of
                                  securities offered (if the total dollar value
                                  of securities offered would not exceed that
                                  which was registered) and any deviation from
                                  the low or high and of the estimated maximum
                                  offering range may be reflected in the form
                                  of prospectus filed with the Commission
                                  pursuant to Rule 424(b) if, in the aggregate,
                                  the changes in volume and price represent no
                                  more than 20 percent change in the maximum
                                  aggregate offering price set forth in the
                                  "Calculation of Registration Fee" table in
                                  the effective registration statement.

                                  (iii)    To include any material information
                                  with respect to the plan of distribution not
                                  previously disclosed in the registration
                                  statement or any material change to such
                                  information in the registration statement;

                          Provided, however, that paragraphs (a)(1)(i) and
                          (a)(1)(ii) do not apply if the information required
                          to be included in a post-effective amendment by those
                          paragraphs is contained in periodic reports filed by
                          the Registrant pursuant to Section 13 or Section
                          15(d) of the Securities Exchange Act of 1934 that are
                          incorporated by reference in the registration
                          statement.





                                      II-5
   6

                          (2)     That, for the purpose of determining any
                          liability under the Securities Act of 1933, each such
                          post-effective amendment shall be deemed to be a new
                          registration statement relating to the securities
                          offered therein, and the offering of such securities
                          at that time shall be deemed to be the initial bona
                          fide offering thereof.

                          (3)     To remove from registration by means of a
                          post-effective amendment any of the securities being
                          registered which remain unsold at the termination of
                          the offering.

                 (b)      Filings incorporating subsequent Exchange Act
                 documents by reference.  The undersigned Registrant hereby
                 undertakes that, for purposes of determining any liability
                 under the Securities Act of 1933, each filing of the
                 Registrant's annual report pursuant to Section 13(a) or
                 Section 15(d) of the Securities Exchange Act of 1934 (and,
                 where applicable, each filing of an employee benefit plan's
                 annual report pursuant to Section 15(d) of the Securities
                 Exchange Act of 1934) that is incorporated by reference in the
                 registration statement shall be deemed to be a new
                 registration statement relating to the securities offered
                 therein, and the offering of such securities at that time
                 shall be deemed to be the initial bona fide offering thereof.

                 (c)      Filing of registration statement on Form S-8.
                 Insofar as indemnification for liabilities arising under the
                 Securities Act of 1933 may be permitted to directors, officers
                 and controlling persons of the Registrant pursuant to the
                 foregoing provisions, or otherwise, the Registrant has been
                 advised that in the opinion of the Securities and Exchange
                 Commission such indemnification is against public policy as
                 expressed in the Act and is, therefore, unenforceable.  In the
                 event that a claim for indemnification against such
                 liabilities (other than the payment by the Registrant of
                 expenses incurred or paid by a director, officer or
                 controlling person of the Registrant in the successful defense
                 of any action, suit or proceeding) is asserted by such
                 director, officer or controlling person in connection with the
                 securities being registered, the Registrant will, unless in
                 the opinion of its counsel the matter has been settled by
                 controlling precedent, submit to a court of appropriate
                 jurisdiction the question whether such indemnification by it
                 is against public policy as expressed in the Act and will be
                 governed by the final adjudication of such issue.





                                      II-6
   7

                                   SIGNATURES

                 The Registrant.  Pursuant to the requirements of the
Securities Act of 1933, the Registrant certifies that it has reasonable grounds
to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Marietta, State of
Georgia, on March 21, 1996.


                                        MATRIA HEALTHCARE, INC.




                                        By:      \s\Parker H. Petit          
                                                 ----------------------------
                                                 Parker H. Petit
                                                 Chairman of the Board





                                      II-7
   8
                                   SIGNATURES

                 KNOW ALL MEN BY THESE PRESENTS, that each person whose
signature appears below constitutes and appoints Robert F. Byrnes, Donald R.
Millard, and J. Brent Burkey and each of them, his true and lawful
attorneys-in-fact and agents, with full power of substitution and
resubstitution, for him and in his name, place and stead, in any and all
capacities, to sign any and all amendments to this registration statement, and
to file the same, with all exhibits thereto, and other documents in connection
therewith with the Securities and Exchange Commission, granting unto said
attorneys-in-fact and agents full power and authority to do and to perform each
and every act and thing requisite and necessary to be done in and about the
premises, as fully and to all intents and purposes as he might or would do in
person, hereby ratifying and confirming all that said attorneys-in-fact and
agents, or their substitutes, may lawfully do or cause to be done by virtue
hereof.

                 Pursuant to the requirements of the Securities Act of 1933,
this registration statement has been signed by the following persons in the
capacities and on the date indicated.




                 Signatures                              Title                        Date
                 ----------                              -----                        ----
                                                                          
  /s/ Parker H. Petit                         Chairman of the Board             March 21, 1996
 ------------------------------------------                                                    
 Parker H. Petit

                                              Chief Executive Officer,          March 21, 1996
  /s/ Robert F. Byrnes                        President, Director and
 ------------------------------------------   Secretary                       
 Robert F. Byrnes                             

                                              Senior Vice President and
  /s/ Donald R. Millard                       Chief Financial Officer           March 21, 1996
 ------------------------------------------                                                    
 Donald R. Millard

  /s/ Craig T. Davenport                                Director                March 21, 1996
 ------------------------------------------                                                     
 Craig T. Davenport

                                                        Director                March ____, 1996
 ------------------------------------------                                                     
 Thomas Erickson

  /s/ David L. Goldsmith                                Director                March 21, 1996
 ------------------------------------------                                                    
 David L. Goldsmith

 /s/ Gene P. Guselli                                    Director                March 21, 1996
 ------------------------------------------                                                     
 Gene P. Guselli


  /s/ Carl E. Sanders                                   Director                March 21, 1996
 ------------------------------------------                                                    
 Carl E. Sanders

  /s/ Jackie M. Ward                                    Director                March 21, 1996
 ------------------------------------------                                                     
 Jackie M. Ward

                                                        Director                March ____, 1996
 ------------------------------------------                                                     
 Morris S. Weeden


  /s/ Frederick P. Zuspan, M.D.                         Director                March 21, 1996
 ------------------------------------------                                                    
 Frederick P. Zuspan, M.D.






                                      II-8
   9

                                 EXHIBIT INDEX



Exhibit                                                                              Sequentially
Number   Description                                                                 Numbered Page
- - ------   -----------                                                                 -------------
              
4(a)             Shareholder Rights Agreement dated as of January 30, 1996 between
                 the Registrant and SunTrust Bank.

5                Opinion of Troutman Sanders LLP.

23(a)            Consent of Ernst & Young LLP.

23(b)            Consent of KPMG Peat Marwick LLP.

23(c)            Consent of Troutman Sanders LLP (contained in the opinion 
                 in Exhibit 5).






                                     II-9